1. Home
  2. IX vs WAT Comparison

IX vs WAT Comparison

Compare IX & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

N/A

Current Price

$28.63

Market Cap

27.6B

Sector

Finance

ML Signal

N/A

Logo Waters Corporation

WAT

Waters Corporation

N/A

Current Price

$379.91

Market Cap

23.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IX
WAT
Founded
1950
1958
Country
Japan
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.6B
23.0B
IPO Year
1970
1995

Fundamental Metrics

Financial Performance
Metric
IX
WAT
Price
$28.63
$379.91
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$390.67
AVG Volume (30 Days)
172.5K
552.9K
Earning Date
11-12-2025
11-04-2025
Dividend Yield
2.63%
N/A
EPS Growth
11.37
3.82
EPS
2.62
10.88
Revenue
$20,512,909,787.00
$3,105,638,000.00
Revenue This Year
$8.93
$7.96
Revenue Next Year
$3.27
$6.32
P/E Ratio
$10.71
$34.80
Revenue Growth
6.22
6.90
52 Week Low
$17.75
$275.05
52 Week High
$29.33
$423.56

Technical Indicators

Market Signals
Indicator
IX
WAT
Relative Strength Index (RSI) 65.99 47.26
Support Level $27.61 $372.93
Resistance Level $29.33 $397.55
Average True Range (ATR) 0.27 9.33
MACD 0.08 -3.89
Stochastic Oscillator 66.30 20.27

Price Performance

Historical Comparison
IX
WAT

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: